Oral Nifedipine and Phytosterol, Intravenous Nicardipine, and Oral Nifedipine Only: Three-arm, Retrospective, Cohort Study for Management of Severe Preeclampsia

Overview

Journal Open Life Sci

Specialty Biology

Date 2023 May 30

PMID 37250848

Authors

Shanduo Ma

Limei Zhu

Tiantian Zhou

Ting Qi

Weijun Wang

Affiliations

Soon will be listed here.

Abstract

The treatment of preeclampsia is delivering women and extracting the placenta, but the Chinese Society of Obstetrics and Gynecology guidelines do not recommend the delivery of babies without severe features. The objectives of the study were to compare the effectiveness and safety of nifedipine and phytosterol in combination with nicardipine for the management of severe preeclampsia. Women (19-32 years; gestation age ≥ 30 weeks) with the complication of severe preeclampsia have received 10 mg of oral nifedipine (pregnant women received 10 mg of oralnifedipine, = 112) or 1 mg/h intravenous nicardipine (pregnant women received 1 mg/h intravenous nicardipine (ND cohort), = 115) or oral 10 mg nifedipine and 500 mg phytosterol (pregnant women received oral 10 mg nifedipine and 500 mg phytosterol (np cohort), = 111) until 150/100 mmHg blood pressure was achieved. The time required to achieve the desired blood pressure control was 13 minutes shorter in the NP cohort compared to the NF ( < 0.0001, = 11.605), and 3 minutes shorter compared to the ND ( < 0.0001, = 2.79) cohorts. Stillbirths were reported in 14 (13%), 28 (24%), and 10 (9%) infants, and 13 (12%), 26 (23%), and 10 (9%) infants died from the NF, ND, and NP cohorts, respectively. The undesirable tocolytic effect was reported in 17 (15%) women of the ND cohort. Phytosterol with nifedipine has a synergistic or additive effect on the management of preeclampsia with fewer adverse outcomes.

References

Matsumura H, Takagi K, Seki H, Ono Y, Ichinose S, Masuko H . Placental transfer of intravenous nicardipine and disposition into breast milk during the control of hypertension in women with pre-eclampsia. Hypertens Pregnancy. 2013; 33(1):93-101. DOI: 10.3109/10641955.2013.846367. View

Bellos I, Pergialiotis V, Papapanagiotou A, Loutradis D, Daskalakis G . Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis. Am J Obstet Gynecol. 2020; 223(4):525-537. DOI: 10.1016/j.ajog.2020.03.016. View

Gabay O, Sanchez C, Salvat C, Chevy F, Breton M, Nourissat G . Stigmasterol: a phytosterol with potential anti-osteoarthritic properties. Osteoarthritis Cartilage. 2009; 18(1):106-16. DOI: 10.1016/j.joca.2009.08.019. View

. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020; 135(6):e237-e260. DOI: 10.1097/AOG.0000000000003891. View

Dassah E, Kusi-Mensah E, Morhe E, Odoi A . Maternal and perinatal outcomes among women with hypertensive disorders in pregnancy in Kumasi, Ghana. PLoS One. 2019; 14(10):e0223478. PMC: 6777792. DOI: 10.1371/journal.pone.0223478. View

Serena C, Begot E, Cros J, Hodler C, Fedou A, Nathan-Denizot N . Nicardipine-induced acute pulmonary edema: a rare but severe complication of tocolysis. Case Rep Crit Care. 2014; 2014:242703. PMC: 4156995. DOI: 10.1155/2014/242703. View

Cao W, Wang X, Chen T, Qin M, Wang Z, Wang Q . Successful rescue of antepartum eclampsia in a Chinese patient: Case report. Medicine (Baltimore). 2019; 98(6):e14301. PMC: 6380709. DOI: 10.1097/MD.0000000000014301. View

Heida K, Zeeman G, van Veen T, Hulzebos C . Neonatal side effects of maternal labetalol treatment in severe preeclampsia. Early Hum Dev. 2012; 88(7):503-7. DOI: 10.1016/j.earlhumdev.2011.12.012. View

Nij Bijvank S, Visser W, Duvekot J, Steegers E, Edens M, Roofthooft D . Ketanserin versus dihydralazine for the treatment of severe hypertension in early-onset preeclampsia: a double blind randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2015; 189:106-11. DOI: 10.1016/j.ejogrb.2015.02.002. View

10.

Xiao S, Zhang M, Liang Y, Wang D . Celastrol synergizes with oral nifedipine to attenuate hypertension in preeclampsia: a randomized, placebo-controlled, and double blinded trial. J Am Soc Hypertens. 2017; 11(9):598-603. DOI: 10.1016/j.jash.2017.07.004. View

11.

Wasim T, Agha S, Saeed K, Riaz A . Oral Nifidepine versus IV labetalol in severe preeclampsia: A randomized control trial. Pak J Med Sci. 2020; 36(6):1147-1152. PMC: 7500996. DOI: 10.12669/pjms.36.6.2591. View

12.

Barton J, Sibai B . Controversies Regarding Diagnosis and Treatment of Severe Hypertension in Pregnancy. Clin Obstet Gynecol. 2016; 60(1):198-205. DOI: 10.1097/GRF.0000000000000254. View

13.

Abalos E, Duley L, Steyn D, Gialdini C . Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2018; 10:CD002252. PMC: 6517078. DOI: 10.1002/14651858.CD002252.pub4. View

14.

Poon L, Shennan A, Hyett J, Kapur A, Hadar E, Divakar H . The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019; 145 Suppl 1:1-33. PMC: 6944283. DOI: 10.1002/ijgo.12802. View

15.

Lee H, Lu K, Foo J, Huang I, Fan Y, Tsai P . Different impacts of various tocolytic agents on increased risk of postoperative hemorrhage in preterm labor women undergoing Cesarean delivery: A population-based cohort study. Medicine (Baltimore). 2020; 99(50):e23651. PMC: 7738150. DOI: 10.1097/MD.0000000000023651. View

16.

Ghaedi E, Foshati S, Ziaei R, Beigrezaei S, Kord-Varkaneh H, Ghavami A . Effects of phytosterols supplementation on blood pressure: A systematic review and meta-analysis. Clin Nutr. 2020; 39(9):2702-2710. DOI: 10.1016/j.clnu.2019.12.020. View

17.

Raheem I, Saaid R, Omar S, Tan P . Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. BJOG. 2011; 119(1):78-85. DOI: 10.1111/j.1471-0528.2011.03151.x. View

18.

. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013; 122(5):1122-1131. DOI: 10.1097/01.AOG.0000437382.03963.88. View

19.

Correani A, Visentin S, Cosmi E, Ponchia E, DAronco S, Simonato M . The maternal-fetal gradient of free and esterified phytosterols at the time of delivery in humans. Clin Nutr. 2017; 37(6 Pt A):2107-2112. DOI: 10.1016/j.clnu.2017.10.004. View

20.

Shi D, Yang F, Zhou L, Wang N . Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsia. J Clin Pharm Ther. 2016; 41(6):657-661. DOI: 10.1111/jcpt.12439. View